Schubert & CO Dexcom Inc Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$84.98 - $122.67 $254 - $368	3 Added 37.5%	11 $1,000
Q3 2022 Oct 21, 2022	SELL	$76.35 - $94.18 $305 - $376	-4 Reduced 33.33%	8 $1,000
Q2 2022 Aug 01, 2022	BUY	$67.99 - $132.89 $611 - $1,196	9 Added 300.0%	12 $1,000
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $94 - $130	-1 Reduced 25.0%	3 $2,000
Q4 2021 Jan 28, 2022	BUY	$129.87 - $162.82 $519 - $651	4 New	4 $2,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.